Unger E F
Division of Clinical Trial Design and Analysis, Office of Therapeutics Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD 20852-1428, USA.
Cardiovasc Res. 2001 Feb 16;49(3):497-506. doi: 10.1016/s0008-6363(00)00285-6.
During the last decade, there has been great interest in the potential use of biologic agents and mechanical techniques to enhance myocardial collateral development. Available experimental methods to detect the effects of interventions designed to improve collateral function include assessment of vascular cell proliferation, quantification of vessel number and size, appraisal of myocardial perfusion, and evaluation of myocardial function. The purpose of this review is to discuss the various experimental approaches for the evaluation of coronary collateral development, highlighting the relative strengths and limitations of the commonly used animal models and methods of assessment.
在过去十年中,人们对使用生物制剂和机械技术促进心肌侧支循环发育的潜在用途产生了浓厚兴趣。用于检测旨在改善侧支循环功能的干预措施效果的现有实验方法包括评估血管细胞增殖、量化血管数量和大小、评估心肌灌注以及评价心肌功能。本综述的目的是讨论评估冠状动脉侧支循环发育的各种实验方法,重点介绍常用动物模型和评估方法的相对优势和局限性。